Publications by authors named "Joseph Gallant"

Claim this Profile
T
The characterization of variable new antigen receptors targeting FAP isolated from a novel immunized library.
Gihan S Gunaratne, Joseph P Gallant, Kendahl L Ott, Payson L Broome, Sasha Celada

Commun Biol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of FAP-targeted theranostics discovered by next-generation sequencing-augmented mining of a novel immunized VNAR library.
Gihan S Gunaratne, Joseph P Gallant, Kendahl L Ott, Payson L Broome, Sasha Celada

bioRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and biophysical characterization of a novel domain-swapped camelid antibody specific for fentanyl.
Joseph P Gallant, Dustin Hicks, Ke Shi, Nicholas H Moeller, Brooke Hoppe

J Biol Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking precision gene therapy: harnessing AAV tropism with nanobody swapping at capsid hotspots.
Mareike D Hoffmann, Joseph P Gallant, Aaron M LeBeau, Daniel Schmidt

NAR Mol Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein.
Joseph P Gallant, Hallie M Hintz, Gihan S Gunaratne, Matthew T Breneman, Emma E Recchia

Cancer Res Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung Cancer.
Natalie Y Luo, Rachel L Minne, Joseph P Gallant, Gihan S Gunaratne, Jayden L West

Bioconjug Chem· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking Precision Gene Therapy: Harnessing AAV Tropism with Nanobody Swapping at Capsid Hotspots.
Mareike D Hoffmann, Joseph P Gallant, Aaron M LeBeau, Daniel Schmidt

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography.
Obinna C Ubah, Eric W Lake, Gihan S Gunaratne, Joseph P Gallant, Marie Fernie

Nat Commun· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of - as anti-SARS-CoV-2 nanobody drug candidates.
Gang Ye, Joseph Gallant, Jian Zheng, Christopher Massey, Ke Shi

Elife· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2.
Gang Ye, Joseph P Gallant, Christopher Massey, Ke Shi, Wanbo Tai

bioRxiv· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Fibroblast Activation Protein Alpha Improves Diagnosis of Metastatic Prostate Cancer with Positron Emission Tomography.
Hallie M Hintz, Joseph P Gallant, Donald J Vander Griend, Ilsa M Coleman, Peter S Nelson

Clin Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer.
Paige M Glumac, Joseph P Gallant, Mariya Shapovalova, Yingming Li, Paari Murugan

Clin Cancer Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of natural selection in shaping genetic variation in a promising Chagas disease drug target: Trypanosoma cruzi trans-sialidase.
Joseph P Gallant, Raquel Asunción Lima-Cordón, Silvia A Justi, Maria Carlota Monroy, Toni Viola

Infect Genet Evol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substance P is an early mediator of peritoneal fibrinolytic pathway genes and promotes intra-abdominal adhesion formation.
Anthony J Esposito, Stanley J Heydrick, Michael R Cassidy, Joseph Gallant, Arthur F Stucchi

J Surg Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis